The curriculum for each specialty defines the process of training and the capabilities needed for the award of a certificate of completion of training (CCT). The curriculum includes the assessment system for measuring trainees’ progress comprising workplace based assessment and knowledge based assessment.
The new curriculum given below was implemented in August 2022 and in addition to GIM focusses on 7 specialty specific capabilities in practice (CiPs). These are:
- Performing the clinical assessment, investigation and management of adverse drug reactions, medication errors and overdose at an individual and (where relevant) population level
- Providing specialist management of patients with complex prescribing needs, including multimorbidity, polypharmacy, adherence issues, and medication intolerance
- Providing analysis and expert opinion on pharmacokinetic, pharmacodynamic and pharmacogenomic factors to guide therapeutic decisions
- Providing evidence-based practice and contributing to the evidence base in a therapeutic area of interest
- Advising on the cost effective, safe and rational use of medicines on a population level
- Delivering effective education in clinical pharmacology, therapeutics and prescribing to promote safe and effective use of medicines across the whole workforce
- Providing expertise in the design and delivery of experimental medicine, and other types of clinical pharmacology & therapeutic research, including preclinical and clinical studies
Key information:
Curriculum:
Clinical%20Pharmacology%20and%20Therapeutics%202022%20curriculum%20FINAL_0.pdf
The ARCP decision aid for each specialty defines the targets that have to be achieved for a satisfactory ARCP outcome at the end of each training year. The link for the ARCP decision aid for the new 2022 curriculum is given below
ARCP Decision Aids:
Clinical%20Pharmacology%20%26%20Therapeutics%20%28CPT%29%202022%20ARCP%20Decision%20Aid%20FINAL.pdf
CPT Rough Guide:
https://www.thefederation.uk/sites/default/files/CPT%2520Rough%2520Guide%2520December%25202022%2520%2528002%2529.docx